Bayer gets nod to market Kerendia for heart failure treatment – The Economic Times(Soban News)

1. Bayer gets nod to market Kerendia for heart failure treatment  The Economic Times
2. India becomes second country to get access to Bayer’s Kerendia for heart failure condition  BusinessLine
3. HFSA 2025: Highlighting Treatment Advances in HFpEF  The Cardiology Advisor
4. Role of MRAs in Heart Failure Treatment  AJMC
5. Bayer’s Kerendia Approved in India for Heart Failure Patients with Preserved and Mildly Reduced Ejection Fraction  geneonline.com

​Bayer gets nod to market Kerendia for heart failure treatment  The Economic TimesIndia becomes second country to get access to Bayer’s Kerendia for heart failure condition  BusinessLineHFSA 2025: Highlighting Treatment Advances in HFpEF  The Cardiology AdvisorRole of MRAs in Heart Failure Treatment  AJMCBayer’s Kerendia Approved in India for Heart Failure Patients with Preserved and Mildly Reduced Ejection Fraction  geneonline.com by Soban News (international And National News)